2023
Early Detection and Prognostic Assessment of Cutaneous Melanoma
Kashani-Sabet M, Leachman S, Stein J, Arbiser J, Berry E, Celebi J, Curiel-Lewandrowski C, Ferris L, Grant-Kels J, Grossman D, Kulkarni R, Marchetti M, Nelson K, Polsky D, Seiverling E, Swetter S, Tsao H, Verdieck-Devlaeminck A, Wei M, Bar A, Bartlett E, Bolognia J, Bowles T, B. K, Chu E, Hartman R, Hawryluk E, Jampel R, Karapetyan L, Kheterpal M, Lawson D, Leming P, Liebman T, Ming M, Sahni D, Savory S, Shaikh S, Sober A, Sondak V, Spaccarelli N, Usatine R, Venna S, Kirkwood J. Early Detection and Prognostic Assessment of Cutaneous Melanoma. JAMA Dermatology 2023, 159: 545-553. PMID: 36920356, PMCID: PMC11225588, DOI: 10.1001/jamadermatol.2023.0127.Peer-Reviewed Original ResearchConceptsRisk-stratified approachCutaneous melanomaGEP scorePrognostic assessmentGene expression profile testingMelanoma screeningEarly detectionLow-risk histologyNegative nodal statusDelphi consensus methodReflectance confocal microscopyNodal statusSentinel lymphAdvanced melanomaHistologic featuresScreening eventsScreening practicesConsensus statementConsensus recommendationsSkin lesionsDermoscopic examinationGEP testingConsensus conferenceMelanocytic skin lesionsClinical setting
2012
AAD/ACMS/ASDSA/ASMS 2012 Appropriate Use Criteria for Mohs Micrographic Surgery: A Report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery
Connolly A, Baker D, Coldiron B, Fazio M, Storrs P, Vidimos A, Zalla M, Brewer J, Begolka W, Berger R, Bigby M, Bolognia J, Brodland D, Collins S, Cronin T, Dahl M, Grant‐Kels J, Hanke C, Hruza G, James W, Lober C, McBurney E, Norton S, Roenigk R, Wheeland R, Wisco O. AAD/ACMS/ASDSA/ASMS 2012 Appropriate Use Criteria for Mohs Micrographic Surgery: A Report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. Dermatologic Surgery 2012, 38: 1582-1603. PMID: 22958088, DOI: 10.1111/j.1524-4725.2012.02574.x.Peer-Reviewed Original ResearchConceptsMohs micrographic surgeryAppropriate use criteriaMohs surgeryUse criteriaMicrographic surgeryAmerican CollegeClinical scenariosAmerican SocietyAmerican AcademyUse of MMSClinical practice experienceEvidence-based medicineHealth care deliveryCalifornia Los AngelesPatient characteristicsPatient selectionClinical benefitRatings of appropriatenessAppropriateness MethodRating panelLentigo malignaAverage patientClinical experienceSurgeryPhysician's decision
2004
Estimating the relative risk of developing melanoma in INK4A carriers
Berwick M, Orlow I, Mahabir S, Myskowski P, Coit D, Brady M, Roy P, Song Y, Canchola R, Barz A, Halpern A, Bolognia J, Eng S, Elahi A, Begg C. Estimating the relative risk of developing melanoma in INK4A carriers. European Journal Of Cancer Prevention 2004, 13: 65-70. PMID: 15075790, DOI: 10.1097/00008469-200402000-00010.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCase-Control StudiesChromatography, LiquidCyclin-Dependent Kinase Inhibitor p16FemaleGerm-Line MutationHumansMaleMelanomaMiddle AgedNeoplasms, Multiple PrimaryNevusNucleic Acid DenaturationOdds RatioPilot ProjectsPolymerase Chain ReactionPrevalenceRisk FactorsSkin NeoplasmsSurveys and QuestionnairesConceptsRisk factorsRelative riskMemorial Sloan-Kettering Cancer CenterStudy designSingle primaryCancer risk factorsMultiple primary melanomasRisk of melanomaNumber of neviPigmented lesion clinicNovel study designRare germline mutationsDermatology clinicCancer CenterNew study designsPrimary melanomaLesion clinicHigh prevalencePrimary casesPatientsMultiple primariesMelanomaGermline mutationsPilot studyFair skin
2001
The eclipse naevus: tan centre with stellate brown rim
Schaffer J, Glusac E, Bolognia J. The eclipse naevus: tan centre with stellate brown rim. British Journal Of Dermatology 2001, 145: 1023-1026. PMID: 11899128, DOI: 10.1046/j.1365-2133.2001.04538.x.Peer-Reviewed Original Research
2000
The Clinical Spectrum Of Pigmented Lesions
Schaffer J, Bolognia J. The Clinical Spectrum Of Pigmented Lesions. Clinics In Plastic Surgery 2000, 27: 391-408. PMID: 10941560, DOI: 10.1016/s0094-1298(20)32735-8.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsA spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids.
Chakraborty A, Sodi S, Rachkovsky M, Kolesnikova N, Platt J, Bolognia J, Pawelek J. A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids. Cancer Research 2000, 60: 2512-9. PMID: 10811133.Peer-Reviewed Original ResearchMeSH KeywordsAminopterinAnimalsAnti-Bacterial AgentsAntigens, CDAntineoplastic Combined Chemotherapy ProtocolsCell MovementChemotaxisFlow CytometryGentamicinsHypoxanthineImmunoblottingLung NeoplasmsLysosome-Associated Membrane GlycoproteinsMelanomaMembrane GlycoproteinsMiceMice, Inbred BALB CMicroscopy, ElectronMonophenol MonooxygenaseNeoplasm TransplantationPolymorphism, Restriction Fragment LengthSequence Analysis, DNAThymidineTime FactorsTumor Cells, CulturedA pilot study using nurse education as an intervention to increase skin self-examination for melanoma.
Berwick M, Oliveria S, Luo S, Headley A, Bolognia J. A pilot study using nurse education as an intervention to increase skin self-examination for melanoma. Journal Of Cancer Education 2000, 15: 38-40. PMID: 10730802, DOI: 10.1080/08858190009528651.Peer-Reviewed Original ResearchI. Biopsy Techniques for Pigmented Lesions
Bolognia J. I. Biopsy Techniques for Pigmented Lesions. Dermatologic Surgery 2000, 26: 89-91. PMID: 10632696, DOI: 10.1046/j.1524-4725.2000.00801.x.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
1999
Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma
Poo‐Hwu W, Ariyan S, Lamb L, Papac R, Zelterman D, Hu G, Brown J, Fischer D, Bolognia J, Buzaid A. Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma. Cancer 1999, 86: 2252-2258. PMID: 10590365, DOI: 10.1002/(sici)1097-0142(19991201)86:11<2252::aid-cncr12>3.0.co;2-q.Peer-Reviewed Original ResearchConceptsCancer stage IAmerican Joint CommitteePatient education programStage IYale Melanoma UnitSurveillance scheduleSymptomatic recurrenceMelanoma UnitSurveillance examinationsJoint CommitteeOverall survival rateStage of diseaseDetection of recurrenceAsymptomatic recurrenceAsymptomatic patientsDistant recurrenceLocoregional recurrenceHazard ratioDisease recurrenceInitial visitMore recurrencesMost recurrencesLate recurrenceMelanoma patientsRecurrence groupHemorrhagic lesion at the tentorial incisura in a patient with facial nevus.
Johnson R, Wong J, Awad I, Kim J, Bolognia J, Sawaya R. Hemorrhagic lesion at the tentorial incisura in a patient with facial nevus. Neurosurgery 1999, 45: 1216-21. PMID: 10549940, DOI: 10.1097/00006123-199911000-00041.Peer-Reviewed Case Reports and Technical Notes
1998
Melanoma × Macrophage Fusion Hybrids Acquire Increased Melanogenesis and Metastatic Potential: Altered N‐Glycosylation as an Underlying Mechanism
SODI S, CHAKRABORTY A, PLATT J, KOLESNIKOVA N, ROSEMBLAT S, KEH‐YEN A, BOLOGNIA J, RACHKOVSKY M, ORLOW S, PAWELEK J. Melanoma × Macrophage Fusion Hybrids Acquire Increased Melanogenesis and Metastatic Potential: Altered N‐Glycosylation as an Underlying Mechanism. Pigment Cell & Melanoma Research 1998, 11: 299-309. PMID: 9877101, DOI: 10.1111/j.1600-0749.1998.tb00739.x.Peer-Reviewed Original ResearchConceptsN-glycosylationLAMP-1Parental cellsN-glycosylation inhibitorMelanoma cellsCloudman S91 cellsMetastatic potentialImportant regulatory pathwayAltered N-glycosylationMajority of hybridsParental melanoma cellsCloudman S91 melanoma cellsRegulatory pathwaysMelanosomal proteinsCloudman melanoma cellsMelanotic phenotypeSame proteinS91 melanoma cellsIncreased glycosylationPigmentary systemCell lysatesS91 cellsUnderlying mechanismCloudman cellsGel electrophoresisWhat's new in the treatment of cutaneous melanoma?
Olhoffer I, Bolognia J. What's new in the treatment of cutaneous melanoma? Seminars In Cutaneous Medicine And Surgery 1998, 17: 96-107. PMID: 9669603, DOI: 10.1016/s1085-5629(98)80003-5.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsAntineoplastic Combined Chemotherapy ProtocolsBiopsyCancer VaccinesChemotherapy, AdjuvantClinical Trials as TopicHumansImmunotherapyInterferonsInterleukinsLymph Node ExcisionLymph NodesLymphatic MetastasisMelanomaMohs SurgeryNeoplasm MetastasisNeoplasm StagingRadionuclide ImagingRemission InductionSkin NeoplasmsSurvival RateConceptsExcision of melanomaManagement of melanomaSentinel node biopsyRecent clinical trialsMohs micrographic surgeryForm of vaccinesAdjuvant immunotherapyAdvanced diseaseNode biopsySurgical marginsCutaneous melanomaAlpha interferonMicrographic surgeryClinical trialsLentigo malignaMelanomaBiochemotherapyImmunotherapyBiopsySurgeryMalignaVaccineExcisionDermatologistsDisease
1997
Regional Isolated Perfusion of Extremities for Melanoma: A 20-Year Experience with Drugs Other than L-Phenylalanine Mustard
Ariyan S, Poo W, Bolognia J. Regional Isolated Perfusion of Extremities for Melanoma: A 20-Year Experience with Drugs Other than L-Phenylalanine Mustard. Plastic & Reconstructive Surgery 1997, 99: 1023-1029. PMID: 9091898, DOI: 10.1097/00006534-199704000-00016.Peer-Reviewed Original ResearchConceptsL-phenylalanine mustardRegional isolated perfusionIsolated limb perfusionIsolated perfusionLimb perfusionUpper extremityLower extremitiesTherapeutic isolated limb perfusionNonfatal pulmonary embolusRegional treatment modalityEvidence of diseaseHigh-dose chemotherapyHigh-risk melanomaNumber of patientsDifficult management problemDisease-free controlsTechnique of perfusionLimb recurrenceMeaningful palliationRepeat perfusionsAggressive treatmentPulmonary emboliDose chemotherapyRecurrent melanomaSerious complications
1995
Multiple Primary Melanomas
Ariyan S, Poo W, Bolognia J, Buzaid A, Ariyan T, Ariyan S. Multiple Primary Melanomas. Plastic & Reconstructive Surgery 1995, 96: 1384-1389. PMID: 7480238, DOI: 10.1097/00006534-199511000-00023.Peer-Reviewed Original ResearchConceptsSecond primary melanomaPrimary melanomaPrimary cutaneous melanomaMultiple primary melanomasIncidence of melanomaYale Melanoma UnitFirst malignancySubsequent melanomaFirst diagnosisPoor prognosisCutaneous melanomaMelanoma UnitPatient prognosisMultiple melanomasSubsequent lesionsPatientsInitial melanomaMelanomaPrognosisFirst yearSecond yearReportYearsMalignancyStatistics ReportNeurotropic melanoma with prominent melanization
Barnhill R, Bolognia J. Neurotropic melanoma with prominent melanization. Journal Of Cutaneous Pathology 1995, 22: 450-459. PMID: 8594079, DOI: 10.1111/j.1600-0560.1995.tb00762.x.Peer-Reviewed Case Reports and Technical NotesEnhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine
BOLOGNIA J, SODI S, OSBER M, PAWELEK J. Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine. British Journal Of Dermatology 1995, 133: 349-357. PMID: 8546987, DOI: 10.1111/j.1365-2133.1995.tb02660.x.Peer-Reviewed Original Research
1994
The significance of eccentric foci of hyperpigmentation ('small dark dots') within melanocytic nevi. Analysis of 59 cases.
Bolognia J, Lin A, Shapiro P. The significance of eccentric foci of hyperpigmentation ('small dark dots') within melanocytic nevi. Analysis of 59 cases. JAMA Dermatology 1994, 130: 1013-7. PMID: 8053697, DOI: 10.1001/archderm.130.8.1013.Peer-Reviewed Original Research
1993
Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s).
Petty E, Gibson L, Fountain J, Bolognia J, Yang-Feng T, Housman D, Bale A. Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s). American Journal Of Human Genetics 1993, 53: 96-104. PMID: 8317504, PMCID: PMC1682234.Peer-Reviewed Original ResearchConceptsCutaneous malignant melanomaGerm-line deletionMalignant melanomaPrimary malignant melanomaMelanoma predisposition genePlexiform neurofibromaPulsed-field gel electrophoresisMultiple melanomasPredisposition genesMelanoma tumorigenesisMelanomaTandem repeat polymorphismCytogenetic rearrangementsPatient's DNAHigh-resolution karyotypeMode of inheritanceWomenRole of computed tomography in the staging of primary melanoma.
Buzaid A, Sandler A, Mani S, Curtis A, Poo W, Bolognia J, Ariyan S. Role of computed tomography in the staging of primary melanoma. Journal Of Clinical Oncology 1993, 11: 638-43. PMID: 8478659, DOI: 10.1200/jco.1993.11.4.638.Peer-Reviewed Original ResearchConceptsClinical stage ISecond primary tumorsPrimary melanomaBody CTCT scanNodal metastasisMetastatic melanomaPrimary tumorStage IAJC clinical Stage IEarly melanomaDistant nodal metastasisRegional nodal diseaseUseful imaging studyStage III diseaseCommon radiologic findingsMultiple pulmonary nodulesStaging of patientsSuspicious scansNodal diseaseOccult metastasesRadiologic findingsAnal canalRadiologic abnormalitiesBenign processCutaneous malignant melanoma and atypical moles associated with a constitutional rearrangement of chromosomes 5 and 9
Petty E, Bolognia J, Bale A, Yang‐Feng T. Cutaneous malignant melanoma and atypical moles associated with a constitutional rearrangement of chromosomes 5 and 9. American Journal Of Medical Genetics 1993, 45: 77-80. PMID: 8418665, DOI: 10.1002/ajmg.1320450119.Peer-Reviewed Case Reports and Technical NotesConceptsHereditary cutaneous malignant melanomaCutaneous malignant melanomaMalignant melanomaMultiple primary melanomasMelanoma tumor tissuesUnbalanced reciprocal translocationPrimary melanomaFamily historyTumor tissueMelanomaCell linesLarge kindredChromosome 9pKindredsReciprocal translocationMolecular studiesShort armNumerous studiesChromosome 5